兰州大学机构库

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
阿帕他胺在前列腺癌治疗中的应用 期刊论文
中国新药与临床杂志, 2022, 卷号: 42, 期号: 06, 页码: 390-395
Authors:  姜婧琦;  宋雨童;  王羽含;  杨高阳;  张璐;  王润昌;  张静;  王志平
Favorite  |    Submit date:2023/12/05
阿帕他胺  前列腺肿瘤  受体  雄激素  新型雄激素受体抑制剂  
阿帕他胺在前列腺癌治疗中的应用 期刊论文
中国新药与临床杂志, 2022, 页码: 1-12
Authors:  姜婧琦;  宋雨童;  王羽含;  杨高阳;  张璐瑒;  王润昌;  张静;  王志平
Favorite  |    Submit date:2023/02/22
阿帕他胺  前列腺肿瘤  受体  雄激素  新型雄激素受体抑制剂  
ADAM12在膀胱癌吉西他滨耐药中的作用及机制研究 学位论文
医学硕士, 兰州: 兰州大学, 2023
Authors:  王润昌
Favorite  |    Submit date:2023/11/15
ADAM12  ADAM12  膀胱癌  bladder cancer  吉西他滨耐药  gemcitabine resistance  上皮间质转化  EMT  表皮生长因子受体  EGFR  
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer 期刊论文
Clinical & Translational Oncology, 2022, 卷号: 25, 期号: 5, 页码: 1425-1435
Authors:  Wang, Runchang;  Gao, Dongyang;  Chen, Chaohu;  Fan, Guangrui;  Cheng, Hui;  Tao, Yan;  Lu, Jianzhong;  Tian, Junqiang;  Wang, Yuhan;  Wang, ZP(王志平)...Wang, Runchang;  Gao, Dongyang;  Chen, Chaohu;  Fan, Guangrui;  Cheng, Hui;  Tao, Yan;  Lu, Jianzhong;  Tian, Junqiang;  Wang, Yuhan;  Wang, ZP(王志平)
Favorite  |    Submit date:2023/02/22
ADAM12  Gemcitabine resistance  EGFR  EMT  Bladder cancer  
CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway 期刊论文
FREE RADICAL BIOLOGY AND MEDICINE, 2023, 卷号: 208, 页码: 587-601
Authors:  Gao, Dongyang;  Wang, Runchang;  Gong, Yuwen;  Yu, Xiaoquan;  Niu, Qian;  Yang, Enguang;  Fan, Guangrui;  Ma, Junhai;  Chen, Chaohu;  Tao, Yan...Gao, Dongyang;  Wang, Runchang;  Gong, Yuwen;  Yu, Xiaoquan;  Niu, Qian;  Yang, Enguang;  Fan, Guangrui;  Ma, Junhai;  Chen, Chaohu;  Tao, Yan;  Lu, Jianzhong;  Wang, Zhiping
Favorite  |    Submit date:2023/11/28
Bladder cancer  Cisplatin resistance  CAB39  Autophagy  Reactive oxygen species  Chloroquine